Skip to content

The effect of platelet rich fibrin on neurosensory recovery following sagittal split osteotomy

The effect of platelet rich fibrin on neurosensory recovery following sagittal split osteotomy, A double- blind randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250815066858N1
Enrollment
16
Registered
2025-08-30
Start date
2025-10-12
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurosensory recovery following sagittal split osteotomy.

Interventions

Intervention 1: Intervention group: Platelet-rich fibrin is used after osteotomy and before fixation on one side of the osteotomy (group 1 or intervention). Intervention 2: Control group: Platelet-ric

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: skeletal discrepancy Class II or III patients undergoing bilateral sagittal split osteotomy surgery

Exclusion criteria

Exclusion criteria: History of trauma to the mandible History of orthognathic surgery and genioplasty Obvious nerve damage during surgery, for example, complete or incomplete nerve transection History of medication use due to mental disorders

Design outcomes

Primary

MeasureTime frame
Evaluation of lower lip anesthesia following sagittal split osteotomy. Timepoint: It is done at intervals of one month, three months and six months. Method of measurement: To assess sensory nerve recovery, the brush stroke directional discrimination test using a brush and the 2-point discrimination using a gauge, the patient's self-report of numbness using a Visual Analogue Scale, and the patient's detection of temperature using ethyl chloride spray and cotton swabs are performed.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Razi Avarzamani

Tehran University of Medical Sciences

dr.abolfazlrazi@gmail.com+98 21 8490 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026